相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

在卵巢癌细胞中,DNMT1通过降低FOXO3a的调节,部分降低了思思丁的敏感性

Chong Guo^1,2, Qingqing Yu³, Fangzhou Li³

¹Department of Obstetrics & Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China.

Journal of chemotherapy (Florence, Italy)

|September 16, 2025

概括

基因甲基转移酶1 (DNMT1) 通过抑制FOXO3a.a.促进卵巢癌 (OC) 中的西斯抗性. 减少DNMT1可以提高化疗的有效性,并改善OC患者的预后.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

锡斯普拉丁耐药性是卵巢癌 (OC) 治疗的一个主要挑战.
DNA甲基转移酶1 (DNMT1) 和FOXO3a与OC中的化学抵抗有关.
了解DNMT1,FOXO3a和西斯白敏感性之间的相互作用至关重要.

研究的目的:

调查DNMT1在调节卵巢癌中思丁敏感性的作用.
为了阐明DNMT1,FOXO3a表达和化学抵抗之间的关系.
探索DNMT1和FOXO3a在OC患者的预后意义.

主要方法:

对OC患者数据的生物信息分析.
试验室研究涉及 cisplatin 治疗和 DNMT1 在 OC 细胞中的敲击.
分析DNMT1对FOXO3a表达和促进物甲基化的影响.
对患者生存数据的元分析.

主要成果:

在OC细胞中,西斯普拉丁治疗增加了DNMT1的表达,并降低了FOXO3a的表达.
DNMT1倒置降低了西斯的IC50并恢复了西斯诱导的FOXO3a表达.
DNMT1通过促进物甲基化抑制FOXO3a的表达.
过度表达FOXO3a增强了西斯的敏感性.
高DNMT1表达与OC患者的生存率差相关,而高FOXO3a与改善的生存率相关.

结论:

在卵巢癌细胞中,DNMT1降低了思丁的敏感性,部分原因是通过抑制FOXO3a.
向DNMT1或增强FOXO3a可能代表克服OC中西斯普拉丁耐药性的治疗策略.
DNMT1和FOXO3a作为卵巢癌的潜在预后生物标志物.

关键词:

在 DNMT1 中,DNMT1 是一个字符串.这就是FOXO3a.对于西斯的敏感性甲基化处理的方法卵巢癌是发生在卵巢的癌症.

更多相关视频

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...